BiotechTube
Home/PureTech Health/Marlies Wijsenbeek
MW

Marlies Wijsenbeek

Collaborator - Chair, Erasmus Medical Center ILD program

PureTech Health

Therapeutic Areas

NeuropsychiatryInflammation & FibrosisOncologyMetabolic DiseaseGastrointestinal

PureTech Health Pipeline

DrugIndicationPhase
LYT-100 (Deupirfenidone)Idiopathic Pulmonary Fibrosis (IPF)Phase 2b
LYT-200Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Solid TumorsPhase 1/2
LYT-300Neuropsychiatric ConditionsPhase 2
LYT-310UndisclosedPreclinical
Glyph Platform CandidatesNon-opioid PainPreclinical
Cobenfy™ (KarXT)Schizophrenia in AdultsApproved
EndeavorRx®Pediatric ADHDApproved
Plenity®Weight ManagementApproved

Leadership Team at PureTech Health

RL
Robert Lyne
Chief Executive Officer
EE
Eric Elenko
Co-founder & President
MI
Michael Inbar
Chief Accounting Officer
SB
Sharon Barber-Lui
Interim Chair of the Board of Directors, Audit Committee Member
MH
Michele Holcomb
Non-Executive Director, Audit Committee Member
BB
Bill Bradford
Collaborator - Former SVP InterMune
VC
Vincent Cottin
Collaborator - Professor, Université Claude Bernard Lyon
KF
Kevin Flaherty
Collaborator - Professor, University of Michigan
TM
Toby Maher
Collaborator - Professor & Director of ILD, USC
PN
Paul Noble
Collaborator - Chair, Department of Medicine, Cedars-Sinai
View full PureTech Health profile